Clinical research & EBM · Reference
What is clinical equipoise?
Clinical equipoise is genuine, honest uncertainty within the expert medical community about which arm of a trial is better. It is widely regarded as the ethical justification for randomisation: it is only fair to assign participants by chance when no one knows which treatment is superior.
Uncertainty as an ethical foundation
Randomising a person to a treatment by chance raises an ethical question: how can it be right to let a coin-flip, rather than judgement, decide someone’s care? Clinical equipoise answers that it is acceptable only when there is honest, collective uncertainty about which option is better. If the expert community genuinely does not know whether the new intervention or the comparator is superior, then no participant is knowingly assigned to an inferior treatment, and the randomized controlled trial is a fair way to resolve the question. Equipoise is therefore the ethical hinge on which randomisation turns.
Individual versus community equipoise
A key refinement, associated with the bioethicist Benjamin Freedman, distinguishes the uncertainty of a single clinician from that of the field as a whole. An individual investigator might privately lean towards one arm, yet clinical (community) equipoise holds as long as the expert community remains divided or genuinely uncertain. This matters because it would be hard to run trials if every participating clinician had to be perfectly undecided. Framing equipoise at the level of the community makes ethical trials feasible while still requiring that real, professional disagreement or uncertainty exists.
When equipoise is disturbed
Equipoise is not a one-off check but a continuing condition. As a trial accumulates data, the uncertainty that justified it may dissolve — and if interim results show one arm is clearly better or clearly harmful, equipoise is disturbed and continuing to randomise becomes hard to defend. This is one reason trials are overseen by an independent data monitoring committee empowered to recommend stopping early. Equipoise thus links the design of a trial to its ongoing ethical conduct under Good Clinical Practice, and it is a research-ethics concept rather than guidance about any individual’s care.
Key facts
At a glance
- Definition: Genuine community uncertainty about which arm is better
- Justifies: Randomisation in controlled trials
- Key thinker: Benjamin Freedman (clinical equipoise, 1987)
- Community-level: Holds despite individual clinicians’ leanings
- Continuing: Must persist; disturbed by clear interim results
- Safeguarded by: Independent data monitoring committees
Common questions
FAQ
Why is clinical equipoise important for randomisation?+
Randomisation assigns participants to treatments by chance, which is ethically acceptable only when no one knows which is better. Clinical equipoise — genuine uncertainty in the expert community about the comparative merits of the arms — provides that justification, so no participant is knowingly assigned an inferior treatment.
What is the difference between individual and community equipoise?+
Individual equipoise is one clinician being undecided, whereas clinical or community equipoise, associated with Benjamin Freedman, holds when the expert community as a whole remains genuinely uncertain or divided. The community framing lets ethical trials proceed even when individual investigators privately lean one way.
What happens when equipoise is disturbed during a trial?+
Equipoise must persist throughout a trial. If accumulating data show one arm is clearly superior or harmful, the uncertainty justifying randomisation dissolves and continuing becomes hard to defend. Independent data monitoring committees watch for this and can recommend stopping the trial early.
Going deeper
Related on CASRAI
- Randomized controlled trial →
- Clinical trial →
- Good Clinical Practice →
- Clinical research →
- Clinical research hub →
Sources
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
